About
Accriva Diagnostics is a U.S.-based company that specializes in point-of-care (POC) in vitro diagnostic (IVD) testing, particularly in coagulation, hemostasis, platelet function analysis, and critical care diagnostics. Established in 2013 through the merger of International Technidyne Corporation and Accumetrics, Accriva has developed a range of diagnostic products that are widely recognized and utilized in hospital and clinical environments. Key products include the Hemochron system for Activated Clotting Time (ACT) testing, the VerifyNow system for platelet function analysis, and Avoximeter CO-Oximetry systems for measuring blood oxygenation. Additionally, Accriva offers incision devices like Tenderfoot®, Tenderlett®, and Surgicutt® for blood sampling and coagulation testing. These products enable rapid decision-making during critical procedures, enhancing patient care and clinical outcomes. In 2017, Accriva was acquired by Werfen Group and its subsidiary Instrumentation Laboratory, further strengthening its position in the market for hospital-based POC hemostasis testing. Accriva continues to operate from its San Diego facility, providing innovative diagnostic solutions to healthcare providers worldwide.
Keywords
Company Information
-
Employees 86
-
Founded 2013
-
Annual Revenue $1047000000
Location
180 Hartwell Rd, Bedford, Massachusetts, United States, 01730
